Geriatric Intervention Contribution on Quality of Life of Elderly Patients With Metastatic Neoplasia

NCT ID: NCT03743961

Last Updated: 2020-07-07

Basic Information

• Recruitment Status: TERMINATED
• Total Enrollment: 28 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2018-11-21
• Study Completion Date: 2020-07-02

Brief Summary

The aim of this study is to describe the impact of : Geriatric intervention contribution on quality of life of elderly patients receiving systemic treatments for metastatic neoplasia

Detailed Description

Elderly cancer incidence increases exponentially with advancing age. However, elderly patients are largely underrepresented in cancer treatment trials. The geriatric population presents particular physical, mental, psychological or social specificities that may condition the prognosis especially for patients with metastatic neoplasia. Recently, the measurement of quality of life (QoL) in aging population is being recognized as an important part of clinical decision. It is therefore essential to set up prospective studies to evaluate the impact of oncogeriatric practices on the quality of life of elderly patients with metastatic neoplasia. The main objective of this prospective study is to describe the contribution of geriatric intervention on quality of life for for elderly (> 75 years) with metastatic solid cancer receiving systemic treatment during the first 6 months of their therapeutic management.

Conditions

Systemic Treatment; Metastatic Neoplasia; Elderly Patients

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Group A : control group

Evaluation of quality of life with the EORTC QoL ELD 14 (Quality Qf Life ELDerly patients with 14 Questions) and QoL EORTC Q30 (Quality Qf Life with 30 Questions)

for patients with G8 score > 14/17

No interventions assigned to this group

Group B : geriatric intervention group

Evaluation of quality of life with the EORTC QoL ELD 14 (Quality Qf Life ELDerly patients) and QoL (Quality Qf Life) EORTC Q30 for patients with G8 score ≤14/17 ( in this arm there is two groups : patient who received geriatric intervention before treatment initiation (group A) and group of patient did not received geriatric intervention before treatment initiation( group B))

geriatric intervention

Intervention Type: OTHER

Geriatric intervention

Interventions

geriatric intervention

Geriatric intervention

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patient with solid metastatic neoplasia
• 75 years old or more
• Men or women
• ECOG between 0 and 3
• Patient receiving systemic antineoplasic treatment (chemotherapy, hormonotherapy, immunotherapy, targeted therapy)

Exclusion Criteria

• ECOG 4
• Localized cancer
• Patients already included in a study witch could modify quality of life
• Patient unable to give their consent

• Minimum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Institut de Cancérologie de la Loire

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Blandine De Lavigerie, MD

Role: PRINCIPAL_INVESTIGATOR

Institut de Cancérologie Lucien Neuwirth

Locations

Institut de Cancérologie Lucien Neuwirth

Saint-Priest-en-Jarez, , France

Countries

France

Other Identifiers

2018-A02315-50

Identifier Type: OTHER

Identifier Source: secondary_id

2018-0801

Identifier Type: -

Identifier Source: org_study_id